- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
La Jolla Pharmaceutical (NASDAQ:LJPC), Quotes and News Summary
La Jolla Pharmaceutical (NASDAQ: LJPC)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.010 | 0.000 | -0.0100 | ||||
| REV | 13.100M | 10.425M | -2.675M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
La Jolla Pharmaceutical Questions & Answers
You can purchase shares of La Jolla Pharmaceutical (NASDAQ: LJPC) through any online brokerage.
Other companies in La Jolla Pharmaceutical’s space includes: Alzamend Neuro (NASDAQ:ALZN), Anixa Biosciences (NASDAQ:ANIX), Fortress Biotech (NASDAQ:FBIO), HOOKIPA Pharma (NASDAQ:HOOK) and Curis (NASDAQ:CRIS).
The latest price target for La Jolla Pharmaceutical (NASDAQ: LJPC) was reported by HC Wainwright & Co. on Tuesday, November 26, 2019. The analyst firm set a price target for 0.00 expecting LJPC to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for La Jolla Pharmaceutical (NASDAQ: LJPC) is $3.43 last updated Today at June 27, 2022, 5:22 PM UTC.
There are no upcoming dividends for La Jolla Pharmaceutical.
La Jolla Pharmaceutical’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for La Jolla Pharmaceutical.
La Jolla Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.